Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,029,484
+$79,307 QoQ
Shares Held
13,889
-1.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#840
of 3,140 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 72%
Shared 0%
None 28%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BRADLEY FOSTER & SARGENT INC/CT holds $254,262,538 across 12 Drug Manufacturers - General names. AMGN ranks #6 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
333,906 | $84,802,106 | |
| 2 | ABBV |
AbbVie Inc.
|
219,509 | $55,237,244 | |
| 3 | LLY |
ELI LILLY & Co
|
35,186 | $42,203,147 | |
| 4 | MRK |
Merck & Co., Inc.
|
287,164 | $36,900,574 | |
| 5 | PFE |
Pfizer Inc
|
678,377 | $16,335,318 | |
| 6 | AMGN |
Amgen Inc
This page
|
13,889 | $5,029,484 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
38,875 | $4,911,467 | |
| 8 | NVS |
Novartis AG
|
17,635 | $2,763,757 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,029,484 | 13,889 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,950,177 | 14,069 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,740,430 | 14,483 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $4,067,630 | 14,414 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $4,397,557 | 15,750 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $4,398,774 | 14,119 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,038,356 | 15,494 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $5,219,479 | 16,199 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $5,075,125 | 16,243 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $4,497,658 | 15,819 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,623,009 | 16,051 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,127,884 | 15,359 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,410,005 | 15,359 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $3,226,879 | 13,348 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $3,515,961 | 13,387 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,065,665 | 13,601 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,309,853 | 13,604 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,014,769 | 12,467 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,650,371 | 11,781 | Shares | Sole | 2022-03-11 | |
| 2021-09-30 | $2,214,749 | 10,415 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,452,368 | 10,061 | Shares | Sole | 2021-08-19 | |
| 2021-03-31 | $2,626,687 | 10,557 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $1,508,275 | 6,560 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,716,342 | 6,753 | Shares | Sole | 2020-10-26 | |
| 2020-03-31 | $1,416,069 | 6,985 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||